Amanda Emmett
AbbVie (United States)(US)
Publications by Year
Research Areas
Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory and Cough-Related Research, Inhalation and Respiratory Drug Delivery, Respiratory Support and Mechanisms
Most-Cited Works
- → Salmeterol Plus Theophylline Combination Therapy in the Treatment of COPD(2001)259 cited
- → Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations(2008)245 cited
- → Relationship between quality of life and clinical status in asthma: a factor analysis(2004)236 cited
- → Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast(2000)226 cited
- → Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes(2009)187 cited
- → Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone(2016)155 cited
- → The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma(1999)152 cited
- → Salmeterol Powder Provides Significantly Better Benefit Than Montelukast in Asthmatic Patients Receiving Concomitant Inhaled Corticosteroid Therapy(2001)141 cited
- → Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations(2001)129 cited
- → β2-Receptor Polymorphisms in Patients Receiving Salmeterol with or without Fluticasone Propionate(2009)108 cited